Host Dr. Richard L. Miller interviews Amanda Feilding, founder of the Beckley Foundation, a UK-based think-tank and UN-accredited NGO, whose dual purpose is the scientific investigation of consciousness and the creation of balanced drug policies.

They discuss recent studies conducted by the Beckley Foundation that use brain imaging technologies to analyze the effects of LSD, and to aid our understanding of the mechanism of action of psychedelic substances.